Collegium Pharmaceutical to Present at Four Healthcare Conferences in March
Event summary
- Collegium Pharmaceutical will participate in four investor conferences in Miami from March 9–11, 2026.
- The Barclays Global Healthcare Conference includes a live webcast fireside chat on March 11 at 9:00 a.m. ET.
- Collegium’s strategy focuses on growing its commercial portfolio, with Jornay PM as the lead growth driver.
- The company is headquartered in Stoughton, Massachusetts.
The big picture
Collegium Pharmaceutical’s participation in multiple investor conferences underscores its push to highlight its diversified biopharmaceutical portfolio, particularly its ADHD treatment Jornay PM. The company’s strategy aligns with broader industry trends of focusing on high-growth therapeutic areas and disciplined capital allocation. The upcoming presentations will be key for investors to assess the company’s execution capabilities and market positioning.
What we're watching
- Growth Strategy
- How Collegium’s focus on Jornay PM will drive its neuropsychiatry business expansion.
- Investor Sentiment
- Whether the upcoming conferences will boost investor confidence in Collegium’s strategic direction.
- Execution Risk
- The pace at which Collegium can scale its commercial portfolio while maintaining disciplined capital deployment.